Eduardo Arellano-Rodrigo

10PUBLICATIONS
47CO-AUTHORS
Haematological tumoursAllergyEpigenetics (incl. genome methylation and epigenomics)HaematologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 04, 2026
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

|Apr 28, 2026
Endothelial activation and damage associated with steroid-refractory aGVHD are counteracted by ruxolitinib.

|Oct 28, 2025
Optical genome mapping in myelofibrosis: enhancing prognostic accuracy through high-resolution genomic profiling.

Álvaro Díaz-González, Elvira Mora, Marta Garrote

|Jan 14, 2025
Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis.

Blanca De Moner, Julia Martinez-Sanchez, Marta Garrote

|Sep 28, 2024
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia.

Marta Santaliestra, Marta Garrote, María Soledad Noya

|Aug 30, 2024
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis.

Irene Pastor-Galán, Arturo Pereira, Eduardo Arellano-Rodrigo

Pageof 2

Frequent Collaborators

5 joint publications

Juan-Carlos Hernández-Boluda

4 joint publications

Francisca Ferrer-Marín

4 joint publications

Marta Garrote

3 joint publications

Alberto Alvarez-Larrán